Epithelial Ovarian Cancer
📧 Sign up to get email alerts when something new happens for Epithelial Ovarian Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Study of Maplirpacept (PF-07901801) in Combination With PLD in Patients With Platinum-Resistant Ovarian Cancer [Phase 1, Phase 2]
A Phase 1/2 trial of Maplirpacept in combination with pegylated liposomal doxorubicin for platinum-resistant ovarian cancer was terminated, …
-
CLINICAL_TRIALS trial_result · 2024-10-15Clinical Trial Update: Study of JK08 in Patients with Unresectable Locally Advanced or Metastatic Cancer [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial of JK08 for unresectable locally advanced or metastatic cancer conducted by Salubris Biotherapeutics is cur…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: Study of Safety & Biological Activity of IP IMNN-001 (also Known As GEN-1) with Neoadjuvant Chemo in Ovarian Cancer [Phase 1]
A Phase 1 trial assessing the safety and biological activity of IP IMNN-001 (GEN-1) with neoadjuvant chemotherapy in epithelial ovarian canc…
-
CLINICAL_TRIALS trial_result · 2024-09-19Clinical Trial Update: Study to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Solid Tumors [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating AsiDNA in combination with Olaparib in participants with recurrent solid tumors has completed; the stu…
-
CLINICAL_TRIALS trial_result · 2024-08-07Clinical Trial Update: A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression [Phase 3]
A Phase 3 study of mirvetuximab soravtansine in platinum-resistant, high-FRα epithelial ovarian, primary peritoneal, or fallopian tube cance…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-08-01Clinical Trial Update: A Study of Mirvetuximab Soravtansine vs. Investigator's Choice (IC) of Chemotherapy in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha (FRα) Expression [Phase 3]
Phase 3 trial comparing mirvetuximab soravtansine with investigator's choice chemotherapy in FRα-high, platinum-resistant epithelial ovarian…
-
CLINICAL_TRIALS trial_result · 2024-05-14Clinical Trial Update: Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab [Phase 2]
Phase 2 trial evaluating weekly ixabepilone with or without biweekly bevacizumab in epithelial ovarian cancer and related peritoneal cancers…
-
CLINICAL_TRIALS trial_result · 2024-05-07Clinical Trial Update: CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib [Phase 3]
Phase 3 rollover study CATCH-R provides continued access to rucaparib for eligible patients with metastatic castration-resistant prostate ca…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Study of Metformin With Carboplatin/Paclitaxel Chemotherapy in Patients With Advanced Ovarian Cancer [Phase 1]
This update reports the completion of a Phase 1 study evaluating the safety and feasibility of adding metformin to carboplatin/paclitaxel ch…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: FES-PET to Determine ER-expression in Epithelial Ovarian Cancer [Phase 2]
Phase 2 clinical trial using the FES-PET imaging agent to determine estrogen receptor expression in epithelial ovarian cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Perioperative Early Tiredness (Acute Fatigue) in Patients With Epithelial Ovarian Cancer
A completed clinical trial update examining perioperative early fatigue in patients with epithelial ovarian cancer, including measurements f…
-
CLINICAL_TRIALS trial_result · 2024-04-02Clinical Trial Update: Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC [Phase 2, Phase 3]
Phase 2/3 trial evaluating MRD assessment combined with a personalized vaccine to prevent postoperative recurrence in epithelial ovarian can…
-
CLINICAL_TRIALS trial_result · 2024-02-14Clinical Trial Update: Study of Mirvetuximab Soravtansine in Combination With Bevacizumab, Carboplatin, Pegylated Liposomal Doxorubicin, Pembrolizumab, or Bevacizumab + Carboplatin in Participants With Folate Receptor Alpha (FRα) Positive Advanced Epithelial Ovarian Cancer, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluating mirvetuximab soravtansine in combination with bevacizumab, carboplatin, pegylated liposomal doxorubicin, or pem…
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: A Study to Explore Pamiparib Treatment in Epithelial Ovarian Cancer After Prior PARP Inhibitor Exposure [Phase 2]
A Phase 2 trial investigating pamiparib for epithelial ovarian cancer after prior PARP inhibitor exposure.
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: Study of Avelumab With or Without Entinostat in Participants With Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating avelumab with or without entinostat in advanced epithelial ovarian cancer and peritoneal cancer has completed; re…
-
CLINICAL_TRIALS trial_result · 2023-11-07Clinical Trial Update: Pembrolizumab, Paclitaxel, and Carboplatin in Patients With Advanced Stage Epithelial Ovarian Cancer (EOC). [Phase 2]
Phase 2 trial of pembrolizumab with paclitaxel and carboplatin in advanced epithelial ovarian cancer (and fallopian tube/peritoneal cancers)…
-
CLINICAL_TRIALS trial_result · 2023-09-15Clinical Trial Update: Intraperitoneal Therapy For Ovarian Cancer With Carboplatin Trial [Phase 2, Phase 3]
Trial update for intraperitoneal therapy with carboplatin in epithelial ovarian cancer and related conditions; the study has completed phase…
-
CLINICAL_TRIALS trial_result · 2023-09-07Clinical Trial Update: Study With Wee-1 Inhibitor AZD1775 (MK-1775) and Carboplatin to Treat p53 Mutated Refractory and Resistant Ovarian Cancer [Phase 2]
Phase 2 trial evaluating the combination of a Wee-1 inhibitor (AZD1775/MK-1775) with carboplatin in p53-mutated, refractory/resistant epithe…
-
CLINICAL_TRIALS trial_result · 2023-07-27Clinical Trial Update: Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer [Phase 1, Phase 2]
Phase 1/2 trial comparing weekly versus every-3-weeks carboplatin plus paclitaxel in advanced epithelial ovarian cancer is completed.
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: Effect of Sodium Thiosulfate on Nephrotoxicity of Cisplatin Intraperitoneal Heat-perfusion Chemotherapy [Phase 2]
Phase 2 clinical trial evaluating whether sodium thiosulfate reduces nephrotoxicity from intraperitoneal cisplatin during heat-perfusion che…
-
CLINICAL_TRIALS trial_result · 2023-04-28Clinical Trial Update: Enzalutamide in Patients With Androgen Receptor Positive (AR+) Ovarian, Primary Peritoneal or Fallopian Tube Cancer and One, Two or Three Prior Therapies [Phase 2]
Phase 2 trial update for enzalutamide in AR-positive ovarian, fallopian tube, or primary peritoneal cancer completed with results posted.
-
CLINICAL_TRIALS trial_result · 2023-04-25Clinical Trial Update: Abraxane With Bevacizumab Biosimilar in Patients With Recurrent, Platinum-resistant Epithelial Ovarian Cancer [Phase 2]
Phase 2 trial update investigating Abraxane with bevacizumab biosimilar in patients with recurrent, platinum-resistant epithelial ovarian ca…
-
CLINICAL_TRIALS trial_result · 2023-02-06Clinical Trial Update: Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients [Phase 2]
A Phase 2 clinical trial update on heated intraperitoneal chemotherapy for ovarian cancer, with unclear status.
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer [Phase 3]
A single-arm Phase 3 trial of IMGN853 in Chinese adults with platinum-resistant epithelial ovarian cancer is ongoing, with conditions includ…
-
CLINICAL_TRIALS trial_result · 2022-08-17Clinical Trial Update: Tri Association in Patient With Advanced Epithelial Ovarian Cancer in Relapse [Phase 2]
Phase 2 clinical trial update for Tri Association in patients with advanced epithelial ovarian cancer in relapse (status unknown).